Table 3 Detection for CHD types
Detection rate | ||||
|---|---|---|---|---|
CHD types | N | Auscultation alone | Pulse oximetry alone | Auscultation or pulse oximetry |
Study Period Data | ||||
ASD | 94 | 94 | 0 | 0 |
ASD&PDA | 99 | 99 | 0 | 0 |
COA | 1 | 0 | 1 | 0 |
CTA | 1 | 0 | 1 | 0 |
PAPVC | 2 | 0 | 2 | 0 |
PDA | 157 | 154 | 3 | 0 |
TAPVC | 3 | 0 | 3 | 0 |
TGA | 2 | 0 | 2 | 0 |
TOF | 2 | 0 | 2 | 0 |
VSD | 38 | 35 | 3 | 0 |
VSD&ASD | 21 | 20 | 1 | 0 |
VSD&ASD&PDA | 14 | 12 | 2 | 0 |
VSD&PDA | 24 | 24 | 0 | 0 |
In Total | 458 | 438 | 20 | 0 |
First Half of 2020 Data | ||||
ASD | 6 | 6 | 0 | 0 |
VSD | 8 | 8 | 0 | 0 |
PDA | 10 | 10 | 0 | 0 |
ASD&VSD | 2 | 2 | 0 | 0 |
VSD&PDA | 2 | 2 | 0 | 0 |
TOF | 1 | 0 | 1 | 0 |
TAPVC | 1 | 0 | 1 | 0 |
In total | 30 | 28 | 2 | 0 |